Grant Sean

Track

Insider profile

Performance

Overall performance
3.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 5% 68% 82%
Transactions
25 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 165%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Grant Sean's trades of Vera Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-25 2026-02-23
S Sale
72,363 -7.1%
117.41
US$1,152,172 		72,363 -7.1% 117.41 US$1,152,172
2026-02-23 2026-02-23
PrS Proposed sale
99,560
453.56
US$322,476 		99,560 453.56 US$322,476
2024-04-05 2024-04-03
S Sale
83,260 -31.6%
212.18
US$3,982,539 		83,260 -31.6% 212.18 US$3,982,539
2024-04-05 2024-04-03
S Sale
2,944 -19.7%
39.19
US$115,384 		2,944 -19.7% 39.19 US$115,384
2024-04-05 2024-04-03
S Sale
3,112 -17.3%
38.22
US$118,950 		3,112 -17.3% 38.22 US$118,950
2024-04-05 2024-04-03
S Sale
453 -100.0%
40.05
US$18,144 		453 -100.0% 40.05 US$18,144
2024-04-05 2024-04-03
S Sale
203 -30.9%
39.20
US$7,957 		203 -30.9% 39.20 US$7,957
2024-04-05 2024-04-03
S Sale
201 -23.5%
38.23
US$7,684 		201 -23.5% 38.23 US$7,684
2024-04-05 2024-04-03
S Sale
1,505 -100.0%
40.06
US$60,286 		1,505 -100.0% 40.06 US$60,286
2024-04-05 2024-04-03
S Sale
639 -29.8%
39.19
US$25,044 		639 -29.8% 39.19 US$25,044
2024-04-05 2024-04-03
S Sale
672 -23.9%
38.22
US$25,686 		672 -23.9% 38.22 US$25,686
2024-04-05 2024-04-03
S Sale
867 -100.0%
40.06
US$34,731 		867 -100.0% 40.06 US$34,731
2024-04-05 2024-04-03
S Sale
366 -29.7%
39.19
US$14,342 		366 -29.7% 39.19 US$14,342
2024-04-05 2024-04-03
S Sale
387 -23.9%
38.22
US$14,793 		387 -23.9% 38.22 US$14,793
2024-04-05 2024-04-03
S Sale
177 -100.0%
40.06
US$7,090 		177 -100.0% 40.06 US$7,090
2024-04-05 2024-04-03
S Sale
80 -31.1%
39.22
US$3,137 		80 -31.1% 39.22 US$3,137
2024-04-05 2024-04-03
S Sale
78 -23.3%
38.20
US$2,979 		78 -23.3% 38.20 US$2,979
2024-04-05 2024-04-03
S Sale
7,361 -10.0%
39.25
US$288,927 		7,361 -10.0% 39.25 US$288,927
2024-04-05 2024-04-03
S Sale
11,648 -13.6%
38.13
US$444,080 		11,648 -13.6% 38.13 US$444,080
2024-04-05 2024-04-03
S Sale
10,988 -11.4%
38.65
US$424,708 		10,988 -11.4% 38.65 US$424,708
2024-04-05 2024-04-03
S Sale
69,831 -42.0%
40.05
US$2,796,801 		69,831 -42.0% 40.05 US$2,796,801
2024-04-03 2024-04-03
PrS Proposed sale
118,477
39.50
US$4,679,842 		118,477 39.50 US$4,679,842
2023-06-23 2023-06-23
B Purchase
5,000 +504.0%
16.60
US$83,000 		5,000 +504.0% 16.60 US$83,000
2022-06-16 2022-06-15
B Purchase
992 +inf%
13.60
US$13,492 		992 +inf% 13.60 US$13,492
2022-06-16 2022-06-15
B Purchase
857 +inf%
13.60
US$11,656 		857 +inf% 13.60 US$11,656
2022-06-16 2022-06-15
B Purchase
335 +inf%
13.60
US$4,556 		335 +inf% 13.60 US$4,556
2022-06-16 2022-06-15
B Purchase
2,816 +inf%
13.60
US$38,300 		2,816 +inf% 13.60 US$38,300
2023-02-08 2022-02-06
PP Planned purchase
14,285 +40.1%
7.00
US$99,995 		14,285 +40.1% 7.00 US$99,995